Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Get CME credit for this article
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Silver, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silver, M. R.
(Chest. 2005;128:568S-575S.)
© 2005 American College of Chest Physicians

Anemia in the Long-term Ventilator-Dependent Patient With Respiratory Failure*

Michael R. Silver, MD, FCCP

* From the Division of Pulmonary and Critical Care Medicine, Rush University Medical Center, Chicago, IL.

Correspondence to: Michael R. Silver, MD, FCCP, Associate Vice President, Medical Affairs, Associate Professor of Medicine, Division of Pulmonary and Critical Care Medicine, Rush University Medical Center, 1653 West Congress Parkway, Chicago, IL 60612; e-mail: msilver2{at}rush.edu

Anemia occurs in virtually all critically ill patients receiving long-term mechanical ventilation and has been associated with increased mortality and poor outcomes. Allogeneic RBC transfusions are routinely administered to critically ill anemic patients, especially during lengthy stays in ICUs or in long-term acute care facilities. Although RBC transfusions are a physiologically rational approach to raising hemoglobin levels, they may increase the risk of complications and have been associated with higher mortality in critically ill patients. Treatment with epoetin alfa, an erythropoiesis-stimulating agent, as a means of reducing transfusion requirements has been studied in the critically ill and in patients receiving long-term mechanical ventilation. Promising results have been reported, including a potential survival benefit, although larger and more definitive studies are needed in order to establish whether raising hemoglobin levels affects clinical outcomes in patients receiving mechanical ventilation.

Key Words: epoetin alfa • long-term acute care • mechanical ventilation • RBC transfusion • weaning




This article has been cited by other articles:


Home page
ChestHome page
J. M. Kahn, L. Goitein, D. R. Ouellette, and R. S. Irwin
Pharmaceutical Industry Sponsorship of Journal Supplements
Chest, May 1, 2006; 129(5): 1387 - 1388.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Chest Physicians.